Qualitative Development and Content Validity of the Non–small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument-Reference-Cited by-同舟云学术

Qualitative Development and Content Validity of the Non–small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument

Published:2016-04 Issue:4 Volume:38 Page:794-810
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

McCarrier Kelly P.,Atkinson Thomas M.,DeBusk Kendra P.A.,Liepa Astra M.,Scanlon Michael,Coons Stephen Joel

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference25 articles.

1. American Cancer Society. Cancer Facts and Figures. http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf [Accessed December 9, 2015].

2. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin Proc,2008

3. An evaluation of the impact of large-scale interventions to raise public awareness of a lung cancer symptom;Ironmonger;Br J Cancer,2015

4. Systemic therapy for Stage IV non-small-cell lung cancer: American Society of Clinical Oncology Clinical Practice Guideline Update;Masters;J Clin Oncol,2015

5. The missing voice of patients in drug-safety reporting;Basch;N Engl J Med,2010

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC;New England Journal of Medicine;2023-11-16

2. Clinical perspectives on serum tumor marker use in predicting prognosis and treatment response in advanced non-small cell lung cancer;Tumor Biology;2023-05-23

3. Development of a Conceptual Model of the Patient Experience in Small Cell Lung Cancer: A Qualitative Interview Study;Oncology and Therapy;2023-02-17

4. Qualitative Analysis of the Content Validity of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) in Schizophrenia: A Multi-Stakeholder Perspective;Schizophrenia Bulletin Open;2023-01-01

5. Identifying symptomatic adverse events using the patient‐reported outcomes version of the common terminology criteria for adverse events in patients with non‐small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations;Cancer Medicine;2022-12-30